Industry wants US FDA to reshuffles its priorities on medtech guidelines
This article was originally published in Clinica
Executive Summary
US medtech industry association AdvaMed believes that the US FDA's annual list of medical device guidelines it plans to issue in this fiscal year misses out some important guidelines that are of high priority to industry because of the lack of transparency/predictability in the areas they would cover.